Drug‐Coated Balloon and Drug‐Eluting Stent Safety in Patients With Femoropopliteal and Severe Chronic Kidney Disease

Background Patients with severe‐stage chronic kidney disease (CKD) were excluded from femoropopliteal disease trials evaluating drug‐coated balloons (DCBs) and drug‐eluting stents (DESs) versus plain balloon angioplasty (POBA) and bare metal stents (BMSs). We examined the interaction between CKD sta...

Full description

Bibliographic Details
Main Authors: Jonathan Hanna, Kim G. Smolderen, Yulanka Castro‐Dominguez, Gaëlle Romain, Megan Lee, Jeffrey Turner, Carlos Mena‐Hurtado
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.028622